Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
Nephrology (Carlton, Vic.)|October 23, 2023
Kidney outcomes associated with haematuria and proteinuria trajectories among patients with IgA nephropathy in real-world clinical practice: The Japan Chronic Kidney Disease DatabaseYuichiro Yano, Hajime Nagasu, Hiroshi Kanegae, et al.
Journal of Hepatology|December 28, 2010
Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in ratsToshiaki Nakano, Yu-Fan Cheng, Chia-Yun Lai, et al.
Transplant Immunology|March 3, 2007
Impact of vaccine therapy using nuclear histone H1 on allograft survival in experimental organ transplantationToshiaki Nakano, Shigeru Goto, Chia-Yun Lai, et al.
Toxicology and Applied Pharmacology|April 5, 2008
Propofol pretreatment attenuates LPS-induced granulocyte-macrophage colony-stimulating factor production in cultured hepatocytes by suppressing MAPK/ERK activity and NF-kappaB translocationBruno Jawan, Ying-Hsien Kao, Shigeru Goto, et al.
Molecular Immunology|April 15, 2005
The effects of anti-histone H1 antibody on immune cells responsible for rejection reactionLi-Wen Hsu, Shigeru Goto, Toshiaki Nakano, et al.
Clinical and Experimental Nephrology|January 6, 2025
Development and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney diseaseTakahiro Imaizumi, Takashi Yokota, Kouta Funakoshi, et al.
Scientific Reports|May 20, 2024
Evaluating the associations between compliance with CKD guideline component metrics and renal outcomesZannatun Nyma, Kaori Kitaoka, Yuichiro Yano, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|September 20, 2014
Exploring the length of the common channel of pancreaticobiliary maljunction on magnetic resonance cholangiopancreatographyFumihide Itokawa, Terumi Kamisawa, Toshiaki Nakano, et al.
Diabetes, Obesity & Metabolism|May 8, 2024
Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease DatabaseTomohiko Kanaoka, Hiromichi Wakui, Yuichiro Yano, et al.
Diabetes Research and Clinical Practice|June 15, 2026
B-type natriuretic peptide level reduction and its predictors following sodium-glucose cotransporter 2 inhibitor treatment in patients with diabetic kidney disease: a Japan Chronic Kidney Disease Database Extension analysisTakanori Nagahiro, Masaaki Konishi, Tomohiko Kanaoka, et al.
Pageof 32